Evidence map›Paper›PMID 32997411›Full record

ArticleClinical and translational medicine2020

The overlap between Alzheimer's disease and epilepsy uncovered by transcriptome sequencing.

Xiaowen Jiang, Hongyuan Lu, Wenwu Liu, Zhongchan Wu, Qiong Wu, Xiang Li, Zihua Xu, Fuhai Hui, Qingchun Zhao

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaowen JiangDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Hongyuan LuDepartment of Clinical Pharmacology, China Medical University, Shenyang, P. R. China.
Wenwu LiuDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Zhongchan WuDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Qiong WuDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Xiang LiDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Zihua XuDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Fuhai HuiDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.
Qingchun ZhaoDepartment of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, P. R. China.ORCID https://orcid.org/0000-0001-9256-9971
Shenyang Pharmaceutical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32997411
PMCPMC7507445
OpenAlexW3087261561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.